Medical industry
News and solutions of medical companies.

Innovation // Adverts // Tenders // Outsourcing // Vacancies // Community // Buy & Sell
ÄIO and tilk! launch first commercial skincare product powered by ÄIO's bio-fermented RedOil!
ÄIO, an Estonian biotechnology company developing sustainable, fermentation-derived fats and oils, and natural cosmetics brand tilk! announce the launch of their first commercial product together: Skin Booster Bio-Fermented Serum with ÄIO RedOil.
The product is a significant step for ÄIO, marking its evolution from research and ingredient development to market-ready, consumer-facing applications. Developed by tilk!, the serum combines ÄIO's RedOil with marine and plant-based actives to deliver a high-performance skincare solution grounded in both science and nature. The partnership marks a breakthrough for Estonia's rising biotech and cosmetics sectors, demonstrating how local innovation can shape the future of clean, high‑performance beauty.
Estonian hospitals will rely on ABB UPSs for energy supply security
The new year has started busy for ABB. From this year on, the operation of vital equipment in some of major Estonian hospitals will be ensured by ABB UPS devices even in the event of power outages.
Estonian startup's AI solution revolutionizes the development of antiviral drugs
Estonian HealthTech Startup Nora AI is leveraging the power of artificial intelligence to develop novel antiviral drugs. In collaboration with the Biosafety Laboratory of University of Tartu, the focus is on treating viruses with a global impact. The company's innovation lies in its drug development platform, Nora.
Over 2,000 Healthcare Executives attending HIMSS23, the leading global digital healthcare conference on April 17-21
Chicago – Over 2,000 leading executives have committed to attend HIMSS Global Health Conference & Exhibition, now three weeks away and widely considered the global standard of substantive healthcare strategy and innovation. Refreshed programs and content are expected to bring even more industry leaders to the summit slated for April 17-21 in Chicago.
Swiss scientists develop new device to detect SARS-CoV-2
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device can prove to be a game-changer in the fight against the ongoing COVID-19 pandemic.
Vitestro unveils autonomous blood drawing device, combining artificial intelligence, ultrasound imaging and robotics
Vitestro, a Dutch medical robotics company, today unveiled the world's most advanced autonomous blood drawing device at the annual meeting of the Netherlands Society for Clinical Chemistry and Laboratory Medicine (NVKC) in Rotterdam. Vitestro's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection. The venipuncture technology is adaptable to patients of 16 years of age onwards, comorbidities, and puncture difficulty. From 2023, Vitestro will initiate pivotal clinical studies for regulatory approval in Europe. EU-market introduction is anticipated in 2024.
Longenesis from Latvia wins Fifty Founders Battle pitch competition at TechChill 2021
Longensis, a startup based in Latvia and Hong Hong, has taken home the main prize at TechChill – 10,000 EUR, no strings attached. Gelatex and VREACH divide 250,000 EUR in angel investment from the pan-Baltic syndicate. The leading Baltic tech and startup event brought together over 1,700 attendees from over 600 different organizations from 29 countries, with 178 speakers taking the virtual stage.
Longenesis is a B2B startup offering a platform to biomedical organizations to reduce the length of clinical trials. This is done through enabling direct communication for safe data curation and compliant, consent-enabled biomedical data utilization for research.
YANMAR Powers Promising New COVID-19 Breath Test
On 18 February, a two-week official validation test started of revolutionary new COVID-19 rapid testing method: a breath test with the QuBA (Quick Breath Analyzer). Fast, safe, reliable and - very important - without any nasty swabs in your nose and throat.
The test could be a huge breakthrough in getting social life back on track.

Users take the test by entering the testing cabin and speaking out loud.
Mixed Reality Surgery World Tour - A new step forward in medical innovation
15 surgeons from 13 different countries have undertaken 13 mixed reality orthopedic operations as part of a 24-hour event. The surgeons virtually collaborated using Microsoft HoloLens 2 and Dynamics 365 Remote Assist, and were led by Professor Thomas Grégory of the Avicenne AP-HP Hospital, France.
Medicine’s (virtual) world tour
Professor Grégory and his team led all 13 mixed reality surgeries from the Avicenne AP-HP Hospital. From there, the surgery toured a number of countries, including: France, India, UAE, South Africa, Ukraine, Germany, Belgium, Morocco, Brazil, Bolivia, Mexico, USA, UK.
ABB robots accelerate COVID-19 testing in Singapore
As part of Singapore’s efforts to enhance its nation-wide COVID-19 testing capabilities, ABB’s high-precision robots have been deployed in a new automated laboratory system, known as the Rapid Automated Volume Enhancer (RAVE).
The system automates some of the manual steps usually required in sample processing. Two sets of RAVE and associated equipment can process an industry-topping throughput of close to 4,000 samples a day. RAVE also reduces test contamination and infection risks for laboratory workers.